"Today, typical anti-psychotics that are still under patent, cost something around $200 to $1,000 per month in therapy. Even with this pricing, I think we can go to the billion (or) billions-dollar product," said Wieczorek, the company's founder who holds a majority stake.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/nrtxlmD
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment